Literature DB >> 6450785

The premenstrual syndrome. A psychological evaluation.

S Watts, L Dennerstein, D J Horne.   

Abstract

The aim of the present study was to verify the presence of certain psychological factors in women complaining of the premenstrual syndrome which would differentiate these women from others. Of 42 women initially interviewed, 25 were finally selected for study, on the basis of clear premenstrual/menstrual symptoms. Twenty-three women who did not suffer premenstrual symptoms acted as controls. Women suffering from the premenstrual syndrome had significantly higher levels of 'trait' anxiety (STAI), 'neuroticism' (EPI-B), and more negative attitudes towards their bodies, genitals, sex and masturbation, as measured by a 'Role Acceptance Scale'. Both premenstrual syndrome sufferers and controls held negative attitudes toward menarche and menses.

Entities:  

Mesh:

Year:  1980        PMID: 6450785     DOI: 10.1016/0165-0327(80)90027-0

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  4 in total

1.  Relationship between personality and premenstrual symptoms: a study in five general practices.

Authors:  R J Taylor; I D Fordyce; D A Alexander
Journal:  Br J Gen Pract       Date:  1991-02       Impact factor: 5.386

2.  A comparison of hormone therapy, coping skills training, and relaxation for the relief of premenstrual syndrome.

Authors:  C A Morse; L Dennerstein; E Farrell; K Varnavides
Journal:  J Behav Med       Date:  1991-10

3.  Two components of body-image disturbance are differentially associated with distinct eating disorder characteristics in healthy young women.

Authors:  Yumi Hamamoto; Shinsuke Suzuki; Motoaki Sugiura
Journal:  PLoS One       Date:  2022-01-12       Impact factor: 3.240

4.  The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study.

Authors:  K R Merikangas; M Foeldenyi; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.